Question Two Shelly Pharma Limited (SPL) is a manufacturer of pharmaceutical products. In January 2015, one of its plants suffered a major break down. It was repaired at a cost of Tshs. 1.5 million but the production capacity was reduced significantly. The plant was ready for production on June 30, 2015. At that time the company's engineers advised that the plant could be used at a reduced level for 3 years only. The factory was estimated to have a recoverable amount of Tshs. 19,277,000 at June 30, 2015. Other related information is as under: i. The plant was imported at FOB price of USD 20,800. The payment was made at the time of shipment on July 1, 2005 at Tshs. 2000 per $. Other charges including installation cost amounted to Tshs. 7 million. Installation of the plant was completed on December 31, 2005 and commercial production commenced from April 1, 2006. ii. The company uses straight line method of deprecation. Depreciation is charged from the month the asset is available for use up to the month prior to disposal. At the time of purchase, the estimated useful life of the plant was estimated at 15 years whereas the salvage value was estimated at Tshs. 2.0 million. Based on the report of a professional independent valuer, the plant was revalued on July 1, 2010 at Tshs. 45 million. There was however, no change in estimated useful life of the plant. iv. The factory remained closed from April 1, to June 30, 2012 due to law and order situation. The salvage value has not changed since it was first estimated at the time of purchase. You are required to compute; iii. how amount at which the plant shall be capitalized a 31.12.2005, Revaluation Surphes and new depreciation also impairement of any